SEC Comment Letter for Enveric Biosciences, Inc. (ENVB) (CIK 0000890821) (ENVB) — Sep 29, 2017
Enveric Biosciences, Inc. (ENVB) (CIK 0000890821)
Date: Sept. 29, 2017 · CIK: 0000890821 · Accession: 0000000000-17-034775
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-220499
Letter
Mail Stop 3030 September 29, 2017 Via E -mail Giri Devanur President and Chief Executive Officer AMERI Holdings, Inc. 100 Canal Pointe Blvd., Suite 108 Princeton, NJ 08540
Re: AMERI Holdings, Inc. Registration Statement on Form S-1 Filed September 18, 2017 File No. 333-220499
Dear Mr. Devanur :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Caleb French at (202) 551 -6947 with any questions.
Sincerely,
/s/ Caleb French for
Show Raw Text
Mail Stop 3030 September 29, 2017 Via E -mail Giri Devanur President and Chief Executive Officer AMERI Holdings, Inc. 100 Canal Pointe Blvd., Suite 108 Princeton, NJ 08540 Re: AMERI Holdings, Inc. Registration Statement on Form S-1 Filed September 18, 2017 File No. 333-220499 Dear Mr. Devanur : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Caleb French at (202) 551 -6947 with any questions. Sincerely, /s/ Caleb French for Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Adam W. Finerman, Esq. Olshan Frome Wolosky LLP